410 related articles for article (PubMed ID: 8530650)
1. Failure of oestrogen induced luteinizing hormone surge in women treated with mifepristone (RU 486) every day for 30 days.
Baird DT; Thong KJ; Hall C; Cameron ST
Hum Reprod; 1995 Sep; 10(9):2270-6. PubMed ID: 8530650
[TBL] [Abstract][Full Text] [Related]
2. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
Kazem R; Messinis LE; Fowler P; Groome NP; Knight PG; Templeton AA
Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of ovulation by progestin analogs (agonists vs antagonists): preliminary evidence for different sites and mechanisms of actions.
Heikinheimo O; Gordon K; Williams RF; Hodgen GD
Contraception; 1996 Jan; 53(1):55-64. PubMed ID: 8631191
[TBL] [Abstract][Full Text] [Related]
4. Effect of daily low dose mifepristone on the ovarian cycle and on dynamics of follicle growth.
Cameron ST; Thong KJ; Baird DT
Clin Endocrinol (Oxf); 1995 Oct; 43(4):407-14. PubMed ID: 7586613
[TBL] [Abstract][Full Text] [Related]
5. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.
Liu JH; Garzo G; Morris S; Stuenkel C; Ulmann A; Yen SS
J Clin Endocrinol Metab; 1987 Dec; 65(6):1135-40. PubMed ID: 2824550
[TBL] [Abstract][Full Text] [Related]
6. Estradiol and progesterone-induced slowing of gonadotropin-releasing hormone pulse frequency is not reversed by subsequent administration of mifepristone.
McCartney CR; Blank SK; Marshall JC
Endocrine; 2009 Oct; 36(2):239-45. PubMed ID: 19609733
[TBL] [Abstract][Full Text] [Related]
7. Antiovulatory actions of RU 486: the pituitary is not the primary site of action in vivo.
Heikinheimo O; Gordon K; Lähteenmäki P; Williams RF; Hodgen GD
J Clin Endocrinol Metab; 1995 Jun; 80(6):1859-68. PubMed ID: 7775633
[TBL] [Abstract][Full Text] [Related]
8. Reduction of gonadotropin-releasing hormone pulse frequency is associated with subsequent selective follicle-stimulating hormone secretion in women with polycystic ovarian disease.
Christman GM; Randolph JF; Kelch RP; Marshall JC
J Clin Endocrinol Metab; 1991 Jun; 72(6):1278-85. PubMed ID: 1902845
[TBL] [Abstract][Full Text] [Related]
9. Use of a GnRH antagonist in conjunction with low amplitude, high frequency LH pulses to induce follicular growth without an LH surge and ovulation in ewes.
Dobson H; Campbell BK; Scaramuzzi RJ
Anim Reprod Sci; 1997 Apr; 46(3-4):213-22. PubMed ID: 9231261
[TBL] [Abstract][Full Text] [Related]
10. Temporal relations between plasma concentrations of luteinizing hormone, follicle-stimulating hormone, estradiol-17beta, progesterone, prolactin, and alpha-melanocyte-stimulating hormone during the follicular, ovulatory, and early luteal phase in the bitch.
de Gier J; Kooistra HS; Djajadiningrat-Laanen SC; Dieleman SJ; Okkens AC
Theriogenology; 2006 Apr; 65(7):1346-59. PubMed ID: 16197989
[TBL] [Abstract][Full Text] [Related]
11. Initiation of high dose gonadotrophin-releasing hormone antagonist treatment during the late follicular phase in the macaque abolishes luteal function irrespective of effects upon the luteinizing hormone surge.
Fraser HM; Lunn SF; Morris KD; Deghenghi R
Hum Reprod; 1997 Mar; 12(3):430-5. PubMed ID: 9130734
[TBL] [Abstract][Full Text] [Related]
12. Alteration of gonadotrophin and steroid hormone release, and of ovarian function by a GnRH antagonist in gilts.
Brüssow KP; Schneider F; Nürnberg G
Anim Reprod Sci; 2001 Apr; 66(1-2):117-28. PubMed ID: 11343847
[TBL] [Abstract][Full Text] [Related]
13. Modulation of the action of gonadotrophin surge-attenuating factor by gonadotrophin-releasing hormone.
Messinis IE; Lolis D; Zikopoulos K; Tsahalina E; Seferiadis K; Templeton AA
Hum Reprod; 1994 Aug; 9(8):1437-41. PubMed ID: 7989501
[TBL] [Abstract][Full Text] [Related]
14. The steroid antagonist RU486 given at pro-oestrus induces hypersecretion of follicle-stimulating hormone from oestrus afternoon to early metoestrus in the rat.
Sánchez-Criado JE; Tébar M; Ruiz A; Padrón L
Eur J Endocrinol; 1997 Sep; 137(3):281-6. PubMed ID: 9330593
[TBL] [Abstract][Full Text] [Related]
15. Facilitation or inhibition of the oestradiol-induced gonadotrophin surge in the immature female rat by progesterone: effects on pituitary responsiveness to gonadotrophin-releasing hormone (GnRH), GnRH self-priming and pituitary mRNAs for the progesterone receptor A and B isoforms.
Attardi B; Scott R; Pfaff D; Fink G
J Neuroendocrinol; 2007 Dec; 19(12):988-1000. PubMed ID: 18001329
[TBL] [Abstract][Full Text] [Related]
16. Luteinizing hormone response to gonadotrophin-releasing hormone in normal women undergoing ovulation induction with urinary or recombinant follicle stimulating hormone.
Messinis IE; Milingos S; Zikopoulos K; Hasiotis G; Seferiadis K; Lolis D
Hum Reprod; 1998 Sep; 13(9):2415-20. PubMed ID: 9806260
[TBL] [Abstract][Full Text] [Related]
17. The midcycle gonadotropin surge in normal women occurs in the face of an unchanging gonadotropin-releasing hormone pulse frequency.
Adams JM; Taylor AE; Schoenfeld DA; Crowley WF; Hall JE
J Clin Endocrinol Metab; 1994 Sep; 79(3):858-64. PubMed ID: 7521353
[TBL] [Abstract][Full Text] [Related]
18. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
Filicori M; Campaniello E; Michelacci L; Pareschi A; Ferrari P; Bolelli G; Flamigni C
J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
[TBL] [Abstract][Full Text] [Related]
19. Effect of mifepristone on folliculogenesis in women treated with recombinant FSH.
Messinis IE; Krishnan M; Kazem R; Khadilkar S; Templeton AA
Clin Endocrinol (Oxf); 1997 Mar; 46(3):309-14. PubMed ID: 9156040
[TBL] [Abstract][Full Text] [Related]
20. Triggering of ovulation in human menopausal gonadotrophin-stimulated cycles: comparison between intravenously administered gonadotrophin-releasing hormone (100 and 500 micrograms), GnRH agonist (buserelin, 500 micrograms) and human chorionic gonadotrophin (10,000 IU).
Gerris J; De Vits A; Joostens M; Van Royen E
Hum Reprod; 1995 Jan; 10(1):56-62. PubMed ID: 7745071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
